New Pathway Targets Huntington’s Disease and Amyloid Disorders
Summary: Researchers have determined the molecular structure of the amyloid nucleus—the initial, rate-limiting assembly that triggers amyloid formation in neurodegenerative diseases such as Huntington’s. This discovery points to a new therapeutic strategy: prevent the very first nucleation event. The team found that the nucleus forms within a single protein molecule and that blocking this formation … Read more